Questions about this study?
The HopeStage team will email you.
SuspendedEUCTR 2010-024371-12
A multicenter, Double-blind 58 week Rollover Study to assess the Safety and Tolerability of BMS-820836 in Patients with Treatment Resistant Major Depression.
This historical record does not confirm current site availability.
Historical research recordMultiple countries
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who could participate?
This study is for people with depression. Other eligibility criteria apply.
- Listed locations
- Austria · Finland and 4 more locations
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Suspended
- Enrollment listed in the registry
- 936
- Sponsor
- Bristol-Myers Squibb International Corporation
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United Kingdom, Austria, Finland, ...
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2010-024371-12
- Official title
Show the full official title
A multicenter, Double-blind 58 week Rollover Study to assess the Safety and Tolerability of BMS-820836 in Patients with Treatment Resistant Major Depression.
Recruitment & locations
SuspendedAustria · Finland · Italy
3 more locations
- Spain
- Sweden
- United Kingdom
Registry details
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Bristol-Myers Squibb International Corporation.
Who can participate?
This study is for people with depression. Other eligibility criteria apply.
Is this study still recruiting?
The historical registry lists this study as suspended.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me